|
|
| | Stannsoporfin Basic information |
| Product Name: | Stannsoporfin | | Synonyms: | Cenobamate, racemic mixture;13C6]-Cenobamate, racemic mixture;2H-Tetrazole-2-ethanol, α-(2-chlorophenyl)-, carbamate (ester) (9CI);Cenobamate impurity 8;D4-rac-Cenobamate;rac-Cenobamate | | CAS: | 913087-59-9 | | MF: | C10H10ClN5O2 | | MW: | 267.67 | | EINECS: | | | Product Categories: | | | Mol File: | 913087-59-9.mol |  |
| | Stannsoporfin Chemical Properties |
| Boiling point | 520.8±60.0 °C(Predicted) | | density | 1.56±0.1 g/cm3(Predicted) | | solubility | Acetone: soluble,DMSO: soluble | | form | A crystalline solid | | pka | 12.76±0.50(Predicted) |
| | Stannsoporfin Usage And Synthesis |
| Biological Activity | (±)-Cenobamate is an analytical reference standard categorized as an anticonvulsant.1 (±)-Cenobamate is regulated as a Schedule V compound in the United States. This product is intended for research and forensic applications. | | References | 1.Choi, Y.-M., Kim, C.-G., Kang, Y.-S., et al.Neurotherapeutic azole compounds(2006) |
| | Stannsoporfin Preparation Products And Raw materials |
|